Myricetin 3-galactoside,
Myricetin 3-O-galactoside,
Myricetin 3-O-beta-D-galactopyranoside,
CHEBI:75815,
15648-86-9,
AC1NUS8E,
CHEMBL462244,
MEGxp0_000183,
SCHEMBL2290443,
ACon1_001299,
DTXSID30166087,
myricetin-3-O-beta-D-galactoside,
ZINC31155545,
AKOS032948879,
MCULE-3567431843,
4CN-2591,
AJ-84192,
BRD-K34010557-001-01-9,
Myricetin 3-O-beta-D-Galactopyranoside, >=85% (LC/MS-ELSD),
5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl beta-D-galactopyranoside,
4H-1-Benzopyran-4-one, 3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-,
5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one,
5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one,
NCGC00180655-02!5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one,
Isomyricitrin,
CID5491408,
C21-H20-O13,